American Portfolios Advisors’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

American Portfolios Advisors’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-12	Closed	-$221	–	3347
2020 Q4	$221	Hold	12	–	–	﹤0.01%	2937
2020 Q3	$220	Hold	12	–	–	﹤0.01%	2893
2020 Q2	$180	Hold	12	–	–	﹤0.01%	2805
2020 Q1	$190	Hold	12	–	–	﹤0.01%	2719
2019 Q4	$195	Hold	12	–	–	﹤0.01%	2783
2019 Q3	$178	Hold	12	–	–	﹤0.01%	2767
2019 Q2	$198	Hold	12	–	–	﹤0.01%	2688
2019 Q1	$208	Hold	12	–	–	﹤0.01%	2565
2018 Q4	$212	Hold	12	–	–	﹤0.01%	2346
2018 Q3	$218	Hold	12	–	–	﹤0.01%	2367
2018 Q2	$235	Hold	12	–	–	﹤0.01%	2338
2018 Q1	$211	Hold	12	–	–	﹤0.01%	2266
2017 Q4	$135	Buy	+12	New	+$125	﹤0.01%	2238

American Portfolios Advisors's CBMG Position: Q1 2021 in Review

American Portfolios Advisors sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 12 shares — an estimated $221 sold.

American Portfolios Advisors first reported a position in CBMG in Q4 2017 and held it in 13 quarters. The position peaked at $235 in Q2 2018. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

American Portfolios Advisors reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
American Portfolios Advisors sold 12 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $221.
American Portfolios Advisors first reported a position in Cellular Biomedicine Group, Inc. in Q4 2017 and held it in 13 quarters.
American Portfolios Advisors's Cellular Biomedicine Group, Inc. position peaked at $235 in Q2 2018.
0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on American Portfolios Advisors's 13F filing for Q1 2021, filed 22 Mar 2023.